Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP253957.RA-K9_-O0Q99QocdRZEDEe3o1yP-k4nksbAiCLN4hItv4130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253957.RA-K9_-O0Q99QocdRZEDEe3o1yP-k4nksbAiCLN4hItv4130_provenance.
• NP240840.RAD94jBXHKiIjwqiQadFcoj9DDqNjf3EJcEBAQAM-bjr8130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240840.RAD94jBXHKiIjwqiQadFcoj9DDqNjf3EJcEBAQAM-bjr8130_provenance.
• NP387373.RAYcaYBOxGk8rOOkhGInj6E45TDXQSnVc4s1J2Hqb2_bI130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387373.RAYcaYBOxGk8rOOkhGInj6E45TDXQSnVc4s1J2Hqb2_bI130_provenance.
• NP501188.RAZYoi2kqr2of8QULdT9KX80GQantIW54hUSbACUFqzGM130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501188.RAZYoi2kqr2of8QULdT9KX80GQantIW54hUSbACUFqzGM130_provenance.
• NP706785.RAY5F3C3kl-dxR_XcibWiDGoTqoUNipqvOn4ngzLJxAko130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706785.RAY5F3C3kl-dxR_XcibWiDGoTqoUNipqvOn4ngzLJxAko130_provenance.
• assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP367322.RAUpuLDzRv5If3HEA8ZsIkqGp5jcAKSCAC-mvzzVkjQAg130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367322.RAUpuLDzRv5If3HEA8ZsIkqGp5jcAKSCAC-mvzzVkjQAg130_provenance.
• NP768115.RASRnEeLJrunPnGpWEYm-udvTqke0poGmpoL5t-iG8jXE130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768115.RASRnEeLJrunPnGpWEYm-udvTqke0poGmpoL5t-iG8jXE130_provenance.
• NP1006022.RAfYjso9l6253qo3T0FyHkCu3h_m9zfuUQB3XyNJIcAaU130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006022.RAfYjso9l6253qo3T0FyHkCu3h_m9zfuUQB3XyNJIcAaU130_provenance.
• NP603804.RAMaCqWAGAUQ1DK1DTJbgM92fLmDOCfApxcWsiIKAHyO0130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603804.RAMaCqWAGAUQ1DK1DTJbgM92fLmDOCfApxcWsiIKAHyO0130_provenance.
• assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP948410.RAdkJ3VVeTfbe35l7KbA_K02rVFD8IMZPJ-RcwchLiQRk130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948410.RAdkJ3VVeTfbe35l7KbA_K02rVFD8IMZPJ-RcwchLiQRk130_provenance.
• NP948411.RAb5OBfdefEPQcAq9xDH-F_5tVVTgNI7mJ_CrE4087CqM130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948411.RAb5OBfdefEPQcAq9xDH-F_5tVVTgNI7mJ_CrE4087CqM130_provenance.
• assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1006024.RAl9ziauokhV4eutDWyOomcJ_UYURnPxBHOt_ULuUuQTc130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006024.RAl9ziauokhV4eutDWyOomcJ_UYURnPxBHOt_ULuUuQTc130_provenance.
• NP948418.RAqqJ639nTrUuKWR8s8fEz_CiLkG5Iu6LmilJ12EVYGdw130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948418.RAqqJ639nTrUuKWR8s8fEz_CiLkG5Iu6LmilJ12EVYGdw130_provenance.
• NP367927.RAzxj77Uh23ij1NA3r4BnPGEbSHwKpi9DAV0PLRjIRaog130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367927.RAzxj77Uh23ij1NA3r4BnPGEbSHwKpi9DAV0PLRjIRaog130_provenance.
• NP368181.RANwH4ogeRYTTfRAQbJA-tJ6KNsSgMBp9pUkUd2htEgaw130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368181.RANwH4ogeRYTTfRAQbJA-tJ6KNsSgMBp9pUkUd2htEgaw130_provenance.
• NP768130.RA-D8yHGIdkfmM0CXZQptM3abnfzYyoH6IV_zwRZx4JdA130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768130.RA-D8yHGIdkfmM0CXZQptM3abnfzYyoH6IV_zwRZx4JdA130_provenance.
• NP948415.RAOCXTcQIA--MleD0_J5w0RJjCgAilUqsKfW_cbNATVh4130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948415.RAOCXTcQIA--MleD0_J5w0RJjCgAilUqsKfW_cbNATVh4130_provenance.
• NP948417.RA6famhNsUp47uVoMXcf2CGPeidz0WalKWigMDyjHm9HQ130_assertion description "[The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948417.RA6famhNsUp47uVoMXcf2CGPeidz0WalKWigMDyjHm9HQ130_provenance.